Citation tools

An, Jiabin, and Matthew B. Rettig. "Epidermal growth factor receptor inhibition sensitizes renal cell carcinoma cells to the cytotoxic effects of bortezomib." Molecular Cancer Therapeutics 6.1 (2007): 61-69. Web. 11 April. 2021.